Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities
- PMID: 29943058
- DOI: 10.1007/s00464-018-6307-9
Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities
Retraction in
-
Retraction Note to: Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.Surg Endosc. 2021 Mar;35(3):1492. doi: 10.1007/s00464-021-08298-0. Surg Endosc. 2021. PMID: 33452565 No abstract available.
Abstract
Background: One-Anastomosis Gastric Bypass (OAGB) has exponentially increased in the last decade, as it is associated with very low complications, mortality, readmissions and reoperations rates, and shows excellent short- and long-term benefits of weight loss and resolution of comorbidities. The aim of this study was to compare the effect of SG, RYGB, and OAGB, on short- and long-term weight loss and comorbidities resolution.
Methods: A prospective randomized clinical study of all morbidly obese patients undergoing SG, RYGB, and OAGB, as primary bariatric procedures, was performed. Patients were randomly assigned into 3 groups: those patients undergoing SG, those ones undergoing RYGB and those ones undergoing OAGB. BMI, excess BMI loss (EBMIL) and remission of type 2 diabetes (T2DM), hypertension (HT), and dyslipidemia (DL) were assessed.
Results: 600 patients were included in the study, 200 in each group. Follow-up rate at 5 years postoperatively was 91% in SG group, 92% in RYGB, and 90% in OAGB. OAGB achieves significantly greater EBMIL than RYGB and SG at 1, 2, and 5 years (p < 0.001, respectively). At 5 years, OAGB achieves significantly greater remission of T2DM (p = 0.027), HT (p = 0.006), and DL (p < 0.001) than RYGB and SG. RYGB did not show significant superiority than SG in short- and long-term remission of T2DM and HT, but achieves greater remission of DL (p < 0.001).
Conclusion: OAGB achieves superior mid- and long-term weight loss than RYGB and SG. There are no significant differences in weight loss between SG and RYGB at 1, 2, and 5 years. OAGB achieves better short- and long-term resolution rates of DM, HT, and DL than SG and RYGB. RYGB and SG obtain similar T2DM and HT remissions, but RYGB reaches significantly greater rates of DL remission. ClinicalTrials.gov Identifier: NCT03467646.
Keywords: Dyslipidemia; Hypertension; One-anastomosis gastric bypass; Roux-en-Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes mellitus.
Similar articles
-
Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.Int J Environ Res Public Health. 2020 Oct 20;17(20):7644. doi: 10.3390/ijerph17207644. Int J Environ Res Public Health. 2020. PMID: 33092117 Free PMC article.
-
Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.Medicina (Kaunas). 2023 May 19;59(5):985. doi: 10.3390/medicina59050985. Medicina (Kaunas). 2023. PMID: 37241216 Free PMC article.
-
Comparison of single-anastomosis gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus remission for obese patients: A meta-analysis of randomized controlled trials.Asian J Surg. 2023 Oct;46(10):4152-4160. doi: 10.1016/j.asjsur.2023.03.062. Epub 2023 Mar 29. Asian J Surg. 2023. PMID: 37002039 Review.
-
Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.Obes Surg. 2016 May;26(5):933-40. doi: 10.1007/s11695-015-1865-6. Obes Surg. 2016. PMID: 26341086
-
Efficacy of One Anastomosis Gastric Bypass Versus Sleeve Gastrectomy and Roux-en-Y Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.Obes Surg. 2024 Dec;34(12):4555-4562. doi: 10.1007/s11695-024-07564-z. Epub 2024 Nov 4. Obes Surg. 2024. PMID: 39496986
Cited by
-
Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present.Obes Surg. 2020 Dec;30(12):5001-5011. doi: 10.1007/s11695-020-04921-6. Epub 2020 Aug 21. Obes Surg. 2020. PMID: 32827090
-
From Biliopancreatic Diversion to One Anastomosis Gastric Bypass, Technique Explanation and Outcome.Obes Surg. 2022 Apr;32(4):1405-1408. doi: 10.1007/s11695-022-05942-z. Epub 2022 Feb 8. Obes Surg. 2022. PMID: 35137288 No abstract available.
-
One Anastomosis Gastric Bypass-Mini-Gastric Bypass (OAGB-MGB) Versus Roux-en-Y Gastric Bypass (RYGB)-a Mid-Term Cohort Study with 612 Patients.Obes Surg. 2020 Apr;30(4):1230-1240. doi: 10.1007/s11695-019-04250-3. Obes Surg. 2020. PMID: 31758474
-
Effect of laparoscopic mini-gastric bypass versus laparoscopic sleeve gastrectomy on hypertension and dyslipidemia in obese type 2 diabetes mellitus patients.Ann Med Surg (Lond). 2023 Jul 10;85(9):4334-4341. doi: 10.1097/MS9.0000000000001080. eCollection 2023 Sep. Ann Med Surg (Lond). 2023. PMID: 37663681 Free PMC article.
-
Nutritional Complications After Laparoscopic Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass: A Comparative Systematic Review and Meta-Analysis.Cureus. 2022 Jan 11;14(1):e21114. doi: 10.7759/cureus.21114. eCollection 2022 Jan. Cureus. 2022. PMID: 35036236 Free PMC article. Review.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials